Beyond Air Announces Strategic Collaboration With Getz Healthcare To Commercialize LungFit PH In Asia-Pacific
Portfolio Pulse from Benzinga Newsdesk
Beyond Air, Inc. (NASDAQ:XAIR) has announced a strategic collaboration with Getz Healthcare to commercialize the LungFit PH device in certain countries across the Asia-Pacific region, pending regulatory approvals. Beyond Air is a commercial stage medical device and biopharmaceutical company focused on improving the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors.
September 07, 2023 | 11:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Beyond Air's partnership with Getz Healthcare to commercialize the LungFit PH device in the Asia-Pacific region could potentially expand its market reach and increase revenues, pending regulatory approvals.
The partnership with Getz Healthcare allows Beyond Air to tap into the Asia-Pacific market, which could potentially lead to increased sales and revenues. However, this is contingent upon regulatory approvals, which introduces an element of uncertainty.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100